Topic: Long Covid

Health Secretary Robert F. Kennedy Jr. holds a roundtable to address Long COVID, noting that $1.5 billion in NIH funding has yielded few results. Researchers and advocates call for a broader strategy, including biomarkers for diagnosis and increased participation from the pharmaceutical industry. The hosts express skepticism, suggesting "Long COVID" is a catch-all term used to maintain public focus on the virus and secure more funding.

Advocates claim that Long COVID has surpassed asthma as the most common childhood illness in the United States. The discussion at the HHS roundtable focuses on the need for the FDA to rapidly approve treatments so that disabled Americans can qualify for insurance coverage. The hosts question the data behind these claims, particularly regarding the prevalence of the condition in children.

NPR reported on the anxiety felt by parents and pregnant women following the removal of federal recommendations for COVID-19 vaccinations in certain healthy groups. The report featured individuals who expressed fear that they would lose access to the shots entirely, despite insurance companies confirming continued coverage. Critics characterized the NPR segment as "propaganda" designed to maintain pharmaceutical demand by leveraging the trauma of the early pandemic years.

Dr. Brian Artis has proposed a theory that nicotine can effectively compete with viral venoms for nicotinic acetylcholine receptors, potentially resolving long COVID symptoms. The theory suggests that nicotine has a higher binding affinity for these receptors than the spike protein or ivermectin. Anecdotal evidence from the early pandemic indicated that smokers and vapers appeared to have a lower incidence of severe COVID-19.

NPR's coverage of the vaccine schedule change utilized the term "pregnant people" rather than women, drawing criticism for its editorial stance. The network reported that while healthy kids are at low risk, parents may still want to immunize them to prevent "mild disease" and transmission to vulnerable relatives. Critics argue these reports ignore data from meta-studies regarding the limited efficacy and potential harms of the boosters.

Dr. Michael Osterholm, a prominent infectious disease expert known as "Dr. Doom," reveals he is suffering from long COVID three years into the pandemic. Despite being heavily vaccinated, Osterholm reports significant respiratory issues and an inability to perform athletic exercises. The hosts contrast his current condition with his previous dire public health projections.

Dr. Peter Hotez expressed concern over the FDA's decision to limit universal vaccine recommendations, arguing that the impact of "long COVID" is being ignored. Hotez blamed "conspiracy podcasts" and "anti-vaccine activism" on cable news for undermining public confidence in vaccine safety. He suggested that the removal of such "disinformation" is necessary to restore trust in public health institutions.

The medical term "chronic sequelae" is used to describe the long-term complications of COVID-19, including heart disease and strokes. Dr. Peter Hotez argued that the FDA's requirement for new placebo-controlled trials for every variant is a "way of denying vaccine access" because the costs are prohibitively expensive for pharmaceutical companies. The segment also references Robert F. Kennedy Jr.'s stance on maintaining vaccine access for all Americans.

New medical reports suggest a link between excess weight and the severity of long COVID symptoms, including neurological and cardiovascular disruptions. The discussion predicts that this research will be used to market GLP-1 drugs like Ozempic as a preventative treatment for long COVID complications.

Dr. Deborah Birx is criticized for a media tour comparing Long COVID to the asymptomatic phase of HIV. The hosts suggest this is a "setup" to reframe vaccine injuries as a chronic condition requiring lifelong pharmaceutical intervention, similar to modern HIV treatments.

Violet Affleck, daughter of Ben Affleck and Jennifer Garner, spoke at a Los Angeles Board of Supervisors meeting to demand mask mandates and air filtration in government facilities to combat "Long COVID." The segment characterizes her advocacy as a result of "child abuse" and notes the persistence of mask culture in Hollywood families.

Former CNN host Chris Cuomo admitted on the Patrick Bet-David podcast that he is now taking a regular dose of Ivermectin to treat long COVID. This marks a significant shift for Cuomo, who was previously a staunch proponent of COVID-19 vaccines and critical of those who resisted government mandates. He acknowledged that the clinical community knew Ivermectin was safe and cheap, but the information was suppressed during the height of the pandemic.

Dr. Deborah Birx appeared on Chris Cuomo's program and suggested that vaccine reactions often mirror the symptoms of the natural disease, effectively equating some cases of long COVID with vaccine injury. Birx called for a 9/11-style commission to investigate these health outcomes and address public concerns. Critics noted that while she now calls for transparency, she previously oversaw the lockdown policies that prioritized young nursing personnel over the elderly in long-term care facilities.

NHS England reported that one in 24 people tested positive for coronavirus recently, leading to renewed calls for mandatory face coverings in hospitals. Long COVID sufferers in the UK have shared stories of debilitating fatigue and brain fog lasting years after infection. Skeptics point to the psychological impact of "psy-oping" the public into a state of perpetual fear regarding recurring viral waves and the perceived failure of previous vaccine doses to prevent reinfection.

Dr. Deborah Birx appeared on News Nation to compare the asymptomatic nature of HIV to the long-term effects of COVID-19. Birx discussed how mild COVID cases might cause unseen damage to the immune system and mitochondria, similar to how HIV functioned before symptoms appeared. Critics argue the comparison is part of a marketing push for new long-term COVID treatments.

Researchers at the University of Pennsylvania have identified low serotonin levels in the gut as a potential cause for Long COVID symptoms. The study suggests that viral persistence leads to inflammation that prevents tryptophan absorption. Media coverage of the study is criticized as a "native ad" for SSRIs like Prozac as a solution for neurocognitive symptoms.

Dr. Michael Osterholm discusses new research showing that SARS-CoV-2 can infect white blood cells, leading to an inflammatory response that increases the risk of heart attacks and strokes for up to a year post-infection. The hosts note that this "mechanistic link" confirms what they have been reporting for over a year regarding vascular problems associated with the virus.

CDC Director Mandy Cohen claimed that COVID-19 vaccines decrease the risk of developing Long COVID. However, a peer-reviewed study from Martin Luther University in Germany found that while unvaccinated individuals were at higher risk from the original Wuhan variant, vaccination provides "zero chance" of additional protection against Long COVID. Critics labeled Cohen's statements as misinformation intended to drive booster uptake.

A study led by David Putrino at Mount Sinai identified specific blood biomarkers in Long COVID patients, including 50% lower levels of cortisol and signs of T-cell exhaustion. The research also found the reactivation of dormant viruses like Epstein-Barr and herpes in those suffering from the condition. The study aims to provide a clinical basis for a condition that has largely been diagnosed through subjective symptoms like brain fog and fatigue.

In her first CNN interview, CDC Director Mandy Cohen claimed that the updated vaccine can prevent "long COVID," despite admitting it does not stop transmission. She shared a third-hand anecdote about an "anti-vax" wife refusing a vaccine for a dying husband to illustrate the dangers of misinformation. Critics argue her personal endorsements lack the backing of rigorous human trial data for the latest formulations.